Stable disease (SD) on amivantamab in post-platinum epidermal growth factor receptor (EGFR) exon 20 insertion (Exon20ins) mutated non-small cell lung cancer (NSCLC): A response-based analysis

N. Girard; K. Park; S. Viteri; C.A. Schioppa; J. Diels; M. Oguz; B.H. Rodrigues; N. Rahhali; J. Sermon; F. Ghilotti; T. Li; R.E. Knoblauch; P. Mahadevia; B.C. Cho

doi:10.1016/j.annonc.2022.02.028

YUHSpace

BROWSE

0 135

Cited 0 times in

Stable disease (SD) on amivantamab in post-platinum epidermal growth factor receptor (EGFR) exon 20 insertion (Exon20ins) mutated non-small cell lung cancer (NSCLC): A response-based analysis

Authors: N. Girard ; K. Park ; S. Viteri ; C.A. Schioppa ; J. Diels ; M. Oguz ; B.H. Rodrigues ; N. Rahhali ; J. Sermon ; F. Ghilotti ; T. Li ; R.E. Knoblauch ; P. Mahadevia ; B.C. Cho